Date prepared: June 22, 2023<\/p>\n\n\n\n
Abbreviated name of the issuer:<\/p>\n\n\n\n
CELON PHARMA S.A.<\/p>\n\n\n\n
Subject: List of shareholders holding at least 5% of the votes at the Ordinary General Meeting of Celon Pharma S.A. held on June 22, 2022<\/p>\n\n\n\n
Legal basis<\/p>\n\n\n\n
subs. 70 point 3 of the Act on Public Offering \u2013 General Shareholder’s Meeting, the above 5% list<\/p>\n\n\n\n
Content of the report:<\/p>\n\n\n\n
Acting pursuant to Article 70 point 3 of the Act on Public Offering (…) the Management Board of Celon Pharma S.A. (\u201cCompany\u201d) hereby informs that the shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company held on June 22, 2023 were:<\/p>\n\n\n\n
– Glatton sp. z o.o., holder of 30,027,531 shares in the Company, representing 45,027,531 votes, which constituted 68.2% of the total number of votes in the Company and 90.3% of votes at this Ordinary General Meeting,<\/p>\n\n\n\n
– Generali Otwarty Fundusz Emerytalny, holder of 2,622,334 shares in the Company, representing 2,622,334 votes, which constituted 4.0% of the total number of votes in the Company and 5.3% of votes at this Ordinary General Meeting.<\/p>\n","protected":false},"excerpt":{"rendered":"